SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

CorMedix Reaffirms 2026 Revenue Guidance and Reports Q3 Cash Position

CorMedix Therapeutics reaffirmed its 2026 total revenue guidance and reported its third-quarter cash position.

CRMD
SquawkNews Desk 1 updates Updated Nov 02, 2026, 12:32 PM UTC

Story updates

12:32:16 PM UTC
SquawkNews
CorMedix Backs 2026 Rev $325M-$355M >CRMD

Related stories

Pathfinder Bancorp Reports Q3 Net Interest Income of $10.7 Million L impact | EARNINGS | Nov 02, 2026, 01:33 PM UTC Balmer Lawrie Reports September-Quarter Consolidated Net Profit of 794.9 Million Rupees M impact | EARNINGS | Nov 02, 2026, 01:33 PM UTC Zeo Energy Reports H1 Revenue Growth of 9.2% Zeo reported residential solar revenue of $29.4 million in the first six months of 2026, up 9.2% year over year. Second-quarter revenue rose 23% sequentially. The company is pursui M impact | EARNINGS | Nov 02, 2026, 01:32 PM UTC Marriott CFO Expects Q3 Demand Trends to Continue in Q4 M impact | EARNINGS | Nov 02, 2026, 01:32 PM UTC Fox Stock Rises More Than 4% Premarket as World Cup Boosts Earnings Fox is up more than 4% premarket. Advertising revenue jumped 47%, with the World Cup, political advertising and streaming platform Tubi contributing to the increase. M impact | EARNINGS | Nov 02, 2026, 01:32 PM UTC Alexander's Reports Q3 Adjusted FFO of $7.07 Per Share L impact | EARNINGS | Nov 02, 2026, 01:28 PM UTC